Huang Ma, Liu Xinxin, Ren Yingcong, Huang Qianxia, Shi Yuanzhi, Yuan Ping, Chen Miao
Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi City, Gui Zhou, People's Republic of China.
Drug Des Devel Ther. 2024 Dec 6;18:5709-5728. doi: 10.2147/DDDT.S499037. eCollection 2024.
In intensive care units, acute lung injury (ALI) is a syndrome that is frequently encountered. It is associated with a high rate of morbidity and mortality. Despite the extensive research conducted by the medical community on its treatment, no specific effective drugs have been identified. Quercetin is a natural flavonoid with many biological activities and pharmacological effects. Research indicates that Quercetin can modulate various targets and signaling pathways, inhibiting oxidative stress, inflammatory responses, ferroptosis, apoptosis, fibrosis, and bacterial and viral infections in ALI. This regulation suggests its potential therapeutic application for the condition. Currently, there is no comprehensive review addressing the application of Quercetin in the treatment of ALI. This paper begins with a classification of ALI, followed by a detailed summary of the mechanisms through which Quercetin may treat ALI to evaluate its potential as a novel therapeutic option.
在重症监护病房中,急性肺损伤(ALI)是一种常见的综合征。它与高发病率和死亡率相关。尽管医学界对其治疗进行了广泛研究,但尚未确定具体有效的药物。槲皮素是一种具有多种生物活性和药理作用的天然黄酮类化合物。研究表明,槲皮素可以调节各种靶点和信号通路,抑制ALI中的氧化应激、炎症反应、铁死亡、细胞凋亡、纤维化以及细菌和病毒感染。这种调节表明其在该病症中的潜在治疗应用价值。目前,尚无关于槲皮素在ALI治疗中应用的全面综述。本文首先对ALI进行分类,然后详细总结槲皮素可能用于治疗ALI的机制,以评估其作为一种新型治疗选择的潜力。